PHARMACIA CORP /DE/

Pharmacia Corp /DE/ is a Delaware-incorporated life sciences company whose pharmaceutical research, development, and manufacturing services focus on bringing specialty therapies to market, serving hospitals, specialty pharmacies, and health systems that demand high-quality clinical agents and supply-chain integrity; even without a publicly disclosed ticker, the firm is identified by CIK 67686 and operates under an SIC-style lens that would place it amongst specialty chemical and drug manufacturers, a context that highlights tight regulatory oversight from FDA, DEA, and international equivalents, while its product scope includes biologics, compounded formulations, and contract development programs; strategic customers lean on Pharmacia for compliance support, serialization, and patient-centric access programs that align with formularies, yet the company faces material risks from patent expirations, pricing pressures, supply disruptions, and evolving post-market surveillance requirements; visitors should view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025